Kromek Group PLC (AIM:KMK) said it has entered into a partnership with a blue-chip technology group to develop cadmium zinc telluride (CZT) based detectors for the medical imaging sector.
The unnamed partner, which was said in the statement to provide technology solutions to more than 100,000 customers for healthcare and other applications, and Kromek will integrate the latter's CZT sensors to develop photon-counting computed tomography (CT) applications.
Using CZT sensors with the partner's read-out electronics should ensure better performance from CT detection systems, it said.
Kromek said as the project progresses towards commercialisation, it will ensure there is sufficient production capability to support commercial demand.
Chief executive Arnab Basu said the company has a strong track record of teaming up with leading global technology partners to advance new imaging solutions.
Another partner, as an example, recently launched an advanced imaging system incorporating Kromek's high-performance CZT digital detectors, and earlier in the year the company won a seven-year contract with another top medical imaging manufacturer to integrate the detector technology into medical imaging scanners.
“Our CZT-based products are the enabling technology in ultra high-resolution systems,” Basu said.
“These systems provide clinicians with greater image quality that leads to earlier diagnosis, better patient outcomes and ultimately saves lives. We look forward to working with this new blue-chip partner to make another important advancement in medical imaging technology."